Anti-KRAS antibody [EPR23474-76] - BSA and Azide free
- KO Validated
- RabMAb
- Recombinant
- What is this?
3
(8 Reviews)
|
(0 Publication)
Rabbit Recombinant Monoclonal RASK antibody. Carrier free. Suitable for IP, WB and reacts with Human, Recombinant full length protein - Human samples.
View Alternative Names
KRAS2, RASK2, KRAS, GTPase KRas, K-Ras 2, Ki-Ras, c-K-ras, c-Ki-ras
- WB
Lab
Western blot - Anti-KRAS antibody [EPR23474-76] - BSA and Azide free (AB275885)
This data was developed using ab275876, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes
All lanes:
Western blot - Anti-KRAS antibody [EPR23474-76] (<a href='/en-us/products/primary-antibodies/kras-antibody-epr23474-76-ab275876'>ab275876</a>) at 1/1000 dilution
Lane 1:
Human brain tissue lysate at 40 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 40 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 22 kDa
Observed band size: 21 kDa
false
- WB
Lab
Western blot - Anti-KRAS antibody [EPR23474-76] - BSA and Azide free (AB275885)
This data was developed using ab275876, the same antibody clone in a different buffer formulation. Anti-KRAS antibody [EPR23474-76] (ab275876) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab275876 was shown to bind specifically to KRAS. A band was observed at 21 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in KRAS knockout cell line ab276083 (knockout cell lysate ab284205). To generate this image, wild-type and KRAS knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were VeriBlot for IP Detection Reagent (HRP) (ab131366) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
Lanes 1 - 2:
Western blot - Anti-KRAS antibody [EPR23474-76] (<a href='/en-us/products/primary-antibodies/kras-antibody-epr23474-76-ab275876'>ab275876</a>) at 1/1000 dilution
Lanes 1 - 2:
Western blot - Anti-KRAS antibody [EPR23474-76] - BSA and Azide free (ab275885)
Lane 1:
Wild-type HCT 116 cell lysate at 10 µg
Lane 2:
KRAS knockout HCT 116 cell lysate at 10 µg
Observed band size: 21 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-KRAS antibody [EPR23474-76] - BSA and Azide free (AB275885)
This data was developed using ab275876, the same antibody clone in a different buffer formulation.
KRAS was immunoprecipitated from 0.35 mg Human brain tissue lysate with ab275876 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab275876 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : Human brain tissue lysate 10 ug
Lane 2 : ab275876 IP in Human brain tissue lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab275876 in human brain tissue lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-KRAS antibody [EPR23474-76] (<a href='/en-us/products/primary-antibodies/kras-antibody-epr23474-76-ab275876'>ab275876</a>)
Predicted band size: 22 kDa
Observed band size: 21 kDa
false
- WB
Lab
Western blot - Anti-KRAS antibody [EPR23474-76] - BSA and Azide free (AB275885)
This data was developed using ab275876, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-KRAS antibody [EPR23474-76] (<a href='/en-us/products/primary-antibodies/kras-antibody-epr23474-76-ab275876'>ab275876</a>) at 1/1000 dilution
Lane 1:
His-tagged human KRAS recombinant protein, 10 ng
Lane 2:
His-tagged human HRAS recombinant protein (aa 1-186), 20 ng
Lane 3:
His-tagged human NRAS recombinant protein (aa 1-186), 20 ng
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 22 kDa
Observed band size: 21 kDa
false
Related conjugates and formulations (1)
-
Anti-KRAS antibody [EPR23474-76]
Reactivity data
Product details
ab275885 is the carrier-free version of ab275876.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KRAS influences many cellular processes. It is not part of a complex but acts alone within its pathways. It modulates signal transduction processes which are significant for the control of proliferation apoptosis and cell cycle progress. Mutations within this protein such as KRAS G12V and KRAS G12D lead to continuous activation and can cause uncontrolled cell growth which links them to various cancers. KRAS commonly interacts with proteins like RAF kinase and PI3K signaling components to execute its functions.
Pathways
KRAS is an important component in at least two important signaling pathways: the MAPK/ERK pathway and the PI3K/AKT pathway. These pathways play major roles in regulating gene expression that drives cell growth and division. In the MAPK/ERK pathway KRAS activates RAF which subsequently initiates a phosphorylation cascade that stimulates ERK. This protein also interacts with elements of the PI3K/AKT pathway influencing cellular survival and metabolism. These interactions position KRAS as a vital oncogene in cancer biology.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com